Compare ANGO & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANGO | ERII |
|---|---|---|
| Founded | 1988 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.2M | 400.7M |
| IPO Year | 2004 | 2008 |
| Metric | ANGO | ERII |
|---|---|---|
| Price | $15.87 | $7.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $18.00 | $17.07 |
| AVG Volume (30 Days) | 395.6K | ★ 945.7K |
| Earning Date | 04-02-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 5.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $291,010,000.00 | $134,987,000.00 |
| Revenue This Year | $9.51 | N/A |
| Revenue Next Year | $4.96 | $20.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 10.17 | N/A |
| 52 Week Low | $9.39 | $7.51 |
| 52 Week High | $16.29 | $18.31 |
| Indicator | ANGO | ERII |
|---|---|---|
| Relative Strength Index (RSI) | 60.99 | 44.27 |
| Support Level | $10.56 | $7.51 |
| Resistance Level | $16.20 | $9.18 |
| Average True Range (ATR) | 0.43 | 0.27 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 47.66 | 47.19 |
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.